White label ELPA - ClinicalTrials.eu

Study Comparing Ustekinumab, Infliximab, and Combination Therapy for Patients with Moderate to Severe Ulcerative Colitis

Recruiting

2 1 1 1 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- Ustekinumab
- Infliximab
Study on CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Advanced Sarcoma

Recruiting

1 1 1
Investigated diseases:
- Sarcoma
Investigated drugs:
- Cart45Ra-Nkg2D Cells
Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

Recruiting

1 1 1
Investigated diseases:
- Haematological malignancy
- Neoplasm
Investigated drugs:
- Zilovertamab Vedotin
+6
Study on the Safety and Effectiveness of TransCon CNP for Infants with Achondroplasia

Recruiting

2 1
Investigated diseases:
- Osteochondrodysplasia
+5
Study of AZD3470 alone and in combination with other cancer drugs for patients with advanced solid tumors that are MTAP deficient

Recruiting

1 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Study of Metolazone and Acetazolamide Combination for Patients with Acute Heart Failure and Volume Overload

Recruiting

3 1 1
Investigated diseases:
- Cardiac failure acute
Investigated drugs:
- Acetazolamide
- Metolazone
Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Recruiting

2 1
Investigated drugs:
- Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
+4
Study on the Safety of Bomedemstat for Patients with Myeloproliferative Neoplasms Who Participated in a Previous Bomedemstat Study

Recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Bomedemstat
Study on Abatacept for Patients with IgG4-Related Disease

Recruiting

2 1 1 1
Investigated diseases:
- Immunoglobulin G4 related disease
Investigated drugs:
- Abatacept
Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

Recruiting

3 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Ficlatuzumab
- Cetuximab
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies